Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8232653 | International Journal of Radiation Oncology*Biology*Physics | 2010 | 6 Pages |
Abstract
Only the latency period was a significant factor in the development of RP. No pretreatment clinical or dosimetric factors were significantly associated with Grade â¥3 RP. Patients, especially those with severe pulmonary comorbidities, should be carefully observed for the graphical appearance of RP within a few months during the follow-up period after SBRT.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Atsuya M.D, Ph.D., Toshio M.D., Ph.D., Etsuo M.D., Ph.D., Tatsuji M.D., Ph.D., Naoko M.D., Toshiaki M.D., Naoyuki M.D., Ph.D.,